Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Matet

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Emerging Infectious Diseases|December 4, 2019
Ocular Spiroplasma ixodetis in Newborns, FranceAlexandre Matet, Anne Le Flèche-Matéos, François Doz, et al.
Expert Opinion on Investigational Drugs|August 31, 2023
Retinal stroke: research models, targets and experimental drugsAlejandra Daruich, Matthieu P Robert, Marta Zola, et al.
Retina (Philadelphia, Pa.)|March 19, 2016
EXTRAMACULAR FIBROSIS IN COATS' DISEASEAlejandra Daruich, Alexandre Matet, Hoai V Tran, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 31, 2016
Argus II retinal prosthesis implantation with scleral flap and autogenous temporalis fascia as alternative patch graft material: a 4-year follow-upAlexandre Matet, Nawel Amar, Saddek Mohand-Said, et al.
Retina (Philadelphia, Pa.)|October 18, 2016
VOLUME-RENDERED ANGIOGRAPHIC AND STRUCTURAL OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF MACULAR TELANGIECTASIA TYPE 2Richard F Spaide, Mihoko Suzuki, Lawrence A Yannuzzi, et al.
Retina (Philadelphia, Pa.)|December 29, 2016
SUBFOVEAL NODULE IN COATS' DISEASE: Toward an Updated Classification Predicting Visual PrognosisAlejandra L Daruich, Alexandre P Moulin, Hoai V Tran, et al.
Indian Journal of Ophthalmology|October 23, 2019
Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathyDaren Hanumunthadu, Alexandre Matet, Mohammed Abdul Rasheed, et al.
Retina (Philadelphia, Pa.)|October 11, 2017
CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHYAlexandre Matet, Suzanne Yzer, Emily Y Chew, et al.
The British Journal of Ophthalmology|October 17, 2019
Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathyKhaled Romdhane, Marta Zola, Alexandre Matet, et al.
Translational Vision Science & Technology|March 12, 2016
Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic EpitheliopathyAlejandra Daruich, Alexandre Matet, Ali Dirani, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Emerging Infectious Diseases|December 4, 2019
Ocular Spiroplasma ixodetis in Newborns, FranceAlexandre Matet, Anne Le Flèche-Matéos, François Doz, et al.
Expert Opinion on Investigational Drugs|August 31, 2023
Retinal stroke: research models, targets and experimental drugsAlejandra Daruich, Matthieu P Robert, Marta Zola, et al.
Retina (Philadelphia, Pa.)|March 19, 2016
EXTRAMACULAR FIBROSIS IN COATS' DISEASEAlejandra Daruich, Alexandre Matet, Hoai V Tran, et al.
Clinical Ophthalmology (Auckland, N.Z.)|August 31, 2016
Argus II retinal prosthesis implantation with scleral flap and autogenous temporalis fascia as alternative patch graft material: a 4-year follow-upAlexandre Matet, Nawel Amar, Saddek Mohand-Said, et al.
Retina (Philadelphia, Pa.)|October 18, 2016
VOLUME-RENDERED ANGIOGRAPHIC AND STRUCTURAL OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF MACULAR TELANGIECTASIA TYPE 2Richard F Spaide, Mihoko Suzuki, Lawrence A Yannuzzi, et al.
Retina (Philadelphia, Pa.)|December 29, 2016
SUBFOVEAL NODULE IN COATS' DISEASE: Toward an Updated Classification Predicting Visual PrognosisAlejandra L Daruich, Alexandre P Moulin, Hoai V Tran, et al.
Indian Journal of Ophthalmology|October 23, 2019
Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathyDaren Hanumunthadu, Alexandre Matet, Mohammed Abdul Rasheed, et al.
Retina (Philadelphia, Pa.)|October 11, 2017
CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHYAlexandre Matet, Suzanne Yzer, Emily Y Chew, et al.
The British Journal of Ophthalmology|October 17, 2019
Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathyKhaled Romdhane, Marta Zola, Alexandre Matet, et al.
Translational Vision Science & Technology|March 12, 2016
Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic EpitheliopathyAlejandra Daruich, Alexandre Matet, Ali Dirani, et al.
Pageof 9